血管内取栓后缺血性卒中治疗后液体衰减反转恢复序列血管高信号征的预后价值
本回顾性研究纳入2017年7月至2021年2月连续前循环大血管闭塞急性缺血性卒中患者84例,评估血管内取栓后FVH状态与临床结局的关系。48例(57.1%)出现治疗后FVH,FVH与不完全再通及治疗后DWI低ASPECTS评分显著相关,且为不良结局的独立预测因素,联合模型中加入FVH可显著提升结局预测效能。
要点
- 治疗后FVH见于57.1%取栓后患者,与不完全再通和更大梗死体积相关。
- 治疗后FVH是临床结局的独立预测因素,无FVH者预后更佳。
- 联合模型加入FVH较不加FVH模型显著提升结局预测效能(p=0.004)。
核心结论
- 治疗后FVH可能是与血管内取栓后急性缺血性卒中患者临床结局相关的有效预后标志物。
研究设计与样本
- 回顾性研究,纳入2017年7月至2021年2月连续前循环大血管闭塞患者84例,评估治疗后FVH状态及其他变量,以3个月改良Rankin量表评分0-2分为良好结局。
关键影像表现/征象
- 治疗后FVH与不完全再通显著相关(p<0.05)。
- 治疗后FVH与治疗后弥散加权成像上较低的Alberta卒中项目早期CT改变评分显著相关(p<0.05)。
- 治疗后FVH患者出血转化发生率27.1%,无FVH患者16.7%,差异未达统计学显著(p=0.259)。
诊断标准与关键数值
- 成功再通预测良好结局的OR为0.024(95%CI 0.003-0.194,p<0.05)。
- 入院时较低NIHSS评分预测良好结局的OR为1.196(95%CI 1.017-1.406,p<0.05)。
- 无治疗后FVH预测良好结局的OR为74.690(95%CI 4.624-1206.421,p<0.05)。
- 联合模型(再通+NIHSSpre+治疗后FVH)预测临床结局显著优于不含FVH的联合模型(再通+NIHSSpre)(p=0.004)。
临床应用与阅片要点
- 治疗后FVH状态可在取栓后影像评估中用于辅助判断再通不完全和梗死体积较大。
- 治疗后FVH可作为预后评估的附加影像标志物,结合再通状态和入院NIHSS评分共同判断结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To explore the value of post-treatment fluid-attenuated inversion recovery vascular hyperintensity (FVH) in predicting clinical outcome in patients with acute ischemic stroke (AIS) after endovascular thrombectomy (EVT).
METHODS: This retrospective study reviewed data from consecutive patients with large vessel occlusion of anterior circulation between July 2017 and February 2021. Together with other variables, status of post-treatment FVH was assessed for each patient. Good outcome was defined as a 3-month modified Rankin Scale score of 0-2. Chi-square test, Fisher's exact test, independent-samples t test, multivariate logistic regression analysis, and receiver operating characteristic analysis were used as appropriate.
RESULTS: Among 84 included patients, 48 (57.1%) patients showed post-treatment FVH. Post-treatment FVH significantly correlated with incomplete recanalization (p < 0.05) and low Alberta Stroke Project Early CT Changes Score on post-treatment diffusion-weighted imaging (p < 0.05). Higher incidence of hemorrhage transformation was observed in patients with post-treatment FVH than those without (27.1% vs. 16.7%); however, the difference did not reach significance (p = 0.259). Successful recanalization (odds ratio [OR], 0.024; 95% confidence interval [CI] 0.003-0.194; p < 0.05), lower National Institutes of Health Stroke Scale scores at admission (NIHSSpre) (OR, 1.196; 95% CI, 1.017-1.406; p < 0.05), and no post-treatment FVH (OR, 74.690; 95% CI, 4.624-1206.421; p < 0.05) were found to be independent predictors of good outcomes. Combined models integrating all three independent predictors (recanalization+NIHSSpre+post-treatment FVH) significantly outperformed the combined model without post-treatment FVH (recanalization+NIHSSpre) in predicting clinical outcome (p = 0.004).
CONCLUSIONS: Post-treatment FVH may be an effective prognostic marker associated with clinical outcome in patients with AIS after EVT.
KEY POINTS: • Post-treatment FVH correlates with incomplete recanalization and higher infarct volume. • Post-treatment FVH is independently associated with an unfavorable outcome. • Post-treatment FVH may provide prognostic information in patients with AIS after EVT.
引用
- Xu, Shen, Ma, et al. Prognostic value of post-treatment fluid-attenuated inversion recovery vascular hyperintensity in ischemic stroke after endovascular thrombectomy. Eur Radiol. 2022. PMID: 35665844. doi:10.1007/s00330-022-08886-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。